Sign In
Buy PCRX
$26.41
-0.560 (-2.08%)
At Close: Jul 31, 2026
Supernus Pharmaceuticals (SUPN) Got Some Good News - Markets
09:34am, Tuesday, 16'th Jun 2020
In a report released today, David Amsellem from Piper Sandler upgraded Supernus Pharmaceuticals (SUPN – Research Report) to Buy, with
Ajo LP Makes New Investment in Pacira Biosciences Inc (NASDAQ:PCRX)
07:39am, Monday, 15'th Jun 2020
Ajo LP bought a new position in Pacira Biosciences Inc (NASDAQ:PCRX) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bo
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Teladoc (TDOC – Research Report),
Jun 10, 2020 (CDN Newswire via Comtex) --
A new offering by MarketandResearch.biz entitled Global Wound Silicone Drainage System Market Growth 2020-2025...
Hedge Funds Souring On Pacira Biosciences Inc (PCRX)
08:36pm, Wednesday, 10'th Jun 2020
In this article you are going to find out whether hedge funds think Pacira Biosciences Inc (NASDAQ:PCRX) is a good investment right now. We like to check what the smart money thinks first before doing
The
Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates
12:00am, Monday, 01'st Jun 2020
Despite the FDA tied up with COVID-19-related activities, May turned out to be a positive month for biopharma companies from the perspective of drug approvals. Three new molecular...
Lyra Therapeutics: A Chance To Pick Up This ENT Play As It Plateaus Post-IPO (NASDAQ:LYRA)
03:20pm, Friday, 29'th May 2020
Lyra Therapeutics completed its IPO in late-April selling 3.5m shares at a price of $16 - the higher end of expectations - to raise $56m. The company is focused
Pacira BioSciences to Present at the 2020 Jefferies Virtual Healthcare Conference
11:30am, Wednesday, 27'th May 2020
PARSIPPANY, N.J., May 27, 2020 -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today reported that it will present at the 2020 Jefferies Virtual Healthcare Conference at 9:30 AM ET.
Guggenheim Initiates Coverage On Pacira BioSciences with Neutral Rating
10:16am, Wednesday, 27'th May 2020Hancock Whitney Corp Invests $324,000 in Pacira Biosciences Inc (NASDAQ:PCRX)
07:54am, Wednesday, 27'th May 2020
Hancock Whitney Corp acquired a new position in shares of Pacira Biosciences Inc (NASDAQ:PCRX) in the first quarter, HoldingsChannel.com reports. The institutional investor acquired 9,649 shares of th
May 25, 2020 (Market Insight Reports) --
The MRI Safe Biopsy Needle Market recently published a Global Market research study with more than 100 industry...
Medical Products Market Share – Industry Analysis, Growth, Trends, Product, Top Key Players and Regional Forecast 2020-2026
12:47pm, Monday, 25'th May 2020
May 25, 2020 (Market Insight Reports) --
Selbyville, Delaware, Market Study Report LLC recently added a new title on 2020-2026 Global Medical Products Market...
